Amniotics™ is presently planning several clinical trials with our most advanced pipeline product PulmiCell™ in different respiratory indications, which are later to be followed by additional products from our pipeline of tissue-appropriate cell therapies from amniotic fluid. If you are interested in collaborating you are welcome to reach out.

WP to LinkedIn Auto Publish Powered By :